Raloxifene for postmenopausal osteoporosis.
D015519:Bone Density / Q000187:drug effects; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004965:Estrogen Antagonists / Q000627:therapeutic use*; D005260:Female; D006207:Half-Life; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control*; D010880:Piperidines / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D020849:Raloxifene Hydrochloride; D013923:Thromboembolism / Q000139:chemically induced
D004965:Estrogen Antagonists; D010880:Piperidines; D020849:Raloxifene Hydrochloride